Most cases (70–80%) of infant B-ALL are associated with rearrangements of the KMT2A gene (encoding a histone methyltransferase), which confers an especially poor prognosis2. This evidence concerns the gene KMT2A and precursor B-cell acute lymphoblastic leukemia.